Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jason study: Sulodexide (Vessel) for prevention of recurrent venous thromboembolism in elderly
2019-000570-33Phase 3Active
- Sponsor
- Fondazione Arianna Anticoagulazione
- Start
- Jun 2021
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of sulodexide in venous thromboembolism (VTE), deep vein thrombosis (DVT) and pulmonary embolism (PE) (3 arms), sponsored by Fondazione Arianna Anticoagulazione. Started Jun 2021; status: active.
02
Drugs
sulodexide
03
Conditions
venous thromboembolism (VTE)deep vein thrombosis (DVT)pulmonary embolism (PE)
Beyond the preview
Go deeper on 2019-000570-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-000570-33.